MedTrace Logo

Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants

NCT00206739 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1070

Last updated 2010-03-30

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness of Intermittent Preventive Treatment in Infants (IPTi) with Sulfadoxine-Pyrimethamine to reduce the numbers of malaria attacks, episodes of anemia, and the overall morbidity and mortality

Conditions

Interventions

DRUG

Sulfadoxine (12.5 mg)/Pyrimethamine (250 mg)

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • Deutscher Akademischer Austausch Dienst

    collaborator OTHER

  • The Volkswagen Foundation

    collaborator OTHER

  • Bernhard Nocht Institute for Tropical Medicine

    lead OTHER_GOV

Principal Investigators

  • Ohene Adjei, Prof. Dr. · Kumasi Centre for Collaborative Research in Tropical Medicine

  • Jürgen May, PD Dr. · Bernhard Nocht Institute for Tropical Medicine Hamburg, Infection Epidemiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
4 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2005-09-30
Completion
2005-09-30

Countries

  • Ghana

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00206739 on ClinicalTrials.gov